What's next for checkpoint inhibitors in metastatic urothelial bladder cancer?
Negative results from trial of roniciclib compared to platinum-based chemotherapy for SCLC
CABOSUN trial of cabozantinib - could it change how we treat frontline RCC?
KEYNOTE-006: the efficacy of ipilimumab after pembrolizumab in patients with advanced melanoma
Trial design of ENGOT-OV16/NOVA Phase III trial of niraparib in platinum-sensitive ovarian cancer